In dopamine replacement therapy theory, prolonged use effect of levodopa (dopamine agonist) medication can stimulate BDNF secretion, resulting in an increase in BDNF in advanced PD patients who are primarily on levodopa medication [19]. The gene discussed is BDNF; the disease is Parkinson disease.